Neuland Laboratories Faces SEBI Warning Over Insider Trading Violation

SEBI has issued an administrative warning to Neuland Laboratories for violating insider trading regulations. The warning comes as part of SEBI’s ongoing efforts to tighten compliance and ensure transparency in market dealings.

Key developments:

SEBI flagged a violation under the Prohibition of Insider Trading Regulations, 2015, citing concerns over unauthorized trading activity.

The company reported the breach, indicating that a designated person engaged in a transaction without obtaining prior clearance.

The individual attempted to sell 500 equity shares at Rs. 3,080.80 per share but the transaction was not executed due to technical reasons.

Though the transaction did not materialize, SEBI held that even the attempt was against guidelines of internal trading.

Neuland Laboratories responded by imposing a fine of Rs. 1,54,060 on the individual, which is 10% of the value of the transaction, as per its own internal compliance policy.

The company has sought an explanation from the concerned individual and reinforced its commitment to regulatory adherence.

Market observers note that SEBI’s administrative warnings serve as a crucial reminder for listed entities to maintain stringent oversight of trading activities. While no further punitive action has been announced, the incident underscores the importance of compliance in safeguarding investor interests.

Sources: Value Research, Trendlyne, Business Standard, Moneycontrol.